Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab

Conditions: Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Interventions: Drug: Niraparib Sponsors: Peking University Cancer Hospital& Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials